EVALUATION OF QT INTERVAL DURATION AND DISPERSION AND PROPOSED CLINICAL-CRITERIA IN DIAGNOSIS OF LONG QT SYNDROME IN PATIENTS WITH A GENETICALLY UNIFORM TYPE OF LQT1
H. Swan et al., EVALUATION OF QT INTERVAL DURATION AND DISPERSION AND PROPOSED CLINICAL-CRITERIA IN DIAGNOSIS OF LONG QT SYNDROME IN PATIENTS WITH A GENETICALLY UNIFORM TYPE OF LQT1, Journal of the American College of Cardiology, 32(2), 1998, pp. 486-491
Objectives. This study investigated the ability of QT duration, QT dis
persion (QTD) and clinical diagnostic criteria to correctly identify g
enetically documented LQT1 type long QT syndrome (LQTS) patients, and
to separate symptomatic and asymptomatic LQT1 patients. Background. Ve
ntricular repolarization has played an essential role both in diagnosi
s and risk assessment of LOTS. Today, molecular genetic techniques per
mit unequivocal identification of many LQTS patients. Methods. QT inte
rval and QTD in 12 symptomatic and 18 asymptomatic LQT1 patients and t
heir 43 healthy relatives were evaluated. The sensitivity and specific
ity of upper normal limits of QT interval two QT interval adjustment m
ethods (Bazett's and Fridericia's formulas), and the proposed clinical
criteria for LQTS were assessed. Occurrence of a mutant (D188N) KVLQT
1 gene was considered as the basis of classification into affected and
nonaffected individuals. Results. Diagnostic sensitivity and specific
ity values were 90% and 88% using Bazett's formula, and 80% and 100% u
sing Fridericia's cubic root formula or upper normal limits for QT int
erval. Suggested diagnostic criteria for LOTS reached 100% specificity
, but 47% of the DNA-documented LQT1 patients were classified into the
category of low or intermediate probability of LOTS. QT interval and
heart rate did not differ between symptomatic (464 +/- 47 ms, 70 +/- 9
min(-1)) and asymptomatic 460 +/- 41 ms, 65 +/- 13 min(-1)) LQT1 pati
ents. QTD was increased in symptomatic LQT1 patients compared to unaff
ected relatives (66 +/- 48 vs. 37 +/- 15 ms, p = 0.02), but symptomati
c patients LQT1 did not differ from asymptomatic (45 +/- 19 ms). Concl
usions. Not all LQT1 patients can be distinguished from healthy relati
ves by assessment of QT duration or clinical criteria. Presence of LQT
1 gene can carry the risk of cardiac events even with no or only margi
nal prolongation of QT interval.